HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

latrepirdine (dimebon)

structure
Also Known As:
dimebon; PF 01913539; PF 1913539; PF-01913539; PF-1913539; PF01913539; PF1913539; dimebolin; dimebone; 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)-ethyl)-1H-pyrid(4,3b)indole
Networked: 59 relevant articles (12 outcomes, 28 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bachurin, Sergey O: 9 articles (01/2021 - 05/2003)
2. Buchman, Vladimir L: 6 articles (01/2021 - 07/2009)
3. Bachurin, S O: 5 articles (01/2017 - 06/2000)
4. Ninkina, Natalia: 4 articles (01/2021 - 07/2009)
5. Kukharsky, Michail S: 3 articles (01/2021 - 01/2013)
6. Verdile, Giuseppe: 3 articles (01/2016 - 01/2012)
7. Gandy, S: 3 articles (12/2013 - 08/2013)
8. Martins, R N: 3 articles (12/2013 - 08/2013)
9. Steele, J W: 3 articles (12/2013 - 08/2013)
10. Bezprozvanny, Ilya: 3 articles (10/2010 - 10/2008)

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Huntington Disease (Huntington's Disease)
3. Neurodegenerative Diseases (Neurodegenerative Disease)
4. Disease Progression
5. TDP-43 Proteinopathies

Related Drugs and Biologics

1. latrepirdine (dimebon)
2. Histamine Antagonists (Antihistamines)
3. Methylene Blue (Methylthioninium Chloride)
4. Vaccines
5. Growth Hormone (Somatotropin)
6. Secretagogues
7. Etanercept (Enbrel)
8. tarenflurbil
9. quifenadine
10. Proteins (Proteins, Gene)

Related Therapies and Procedures

1. Therapeutics
2. Activities of Daily Living (ADL)
3. Oral Administration